allotrap has been researched along with Cystitis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belmar, N; Felsen, D; Fong, T; Gonzalez, RR; Saban, M; Te, A | 1 |
van Ophoven, A | 1 |
Chen, X; Deyoung, BR; Evanoff, DP; Liu, W; Luo, Y | 1 |
3 other study(ies) available for allotrap and Cystitis
Article | Year |
---|---|
Modulating bladder neuro-inflammation: RDP58, a novel anti-inflammatory peptide, decreases inflammation and nerve growth factor production in experimental cystitis.
Topics: Animals; Anti-Inflammatory Agents; Cystitis; Female; Histocompatibility Antigens Class I; Mice; Mice, Inbred C57BL; Nerve Growth Factor; Peptides | 2005 |
Re: Modulating bladder neuro-inflammation: RDP58, a novel anti-inflammatory peptide, decreases inflammation and nerve growth factor production in experimental cystitis.
Topics: Administration, Intravesical; Animals; Cell Count; Cystitis; Histocompatibility Antigens Class I; Inflammation; Lipopolysaccharides; Mast Cells; Mice; Nerve Growth Factor; Peptides | 2005 |
RDP58 inhibits T cell-mediated bladder inflammation in an autoimmune cystitis model.
Topics: Animals; Autoimmune Diseases; CD8-Positive T-Lymphocytes; Cystitis; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Immunosuppressive Agents; Injections, Intralesional; Mice; Mice, Transgenic; Peptides; Reverse Transcriptase Polymerase Chain Reaction | 2008 |